Chen Min . The Value of Large Dose of Ambroxol Hydrochloride in Treating Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease[J]. Journal of Kunming Medical University, 2016, 37(01).
Citation: Chen Min . The Value of Large Dose of Ambroxol Hydrochloride in Treating Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease[J]. Journal of Kunming Medical University, 2016, 37(01).

The Value of Large Dose of Ambroxol Hydrochloride in Treating Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

  • [Abstract]Objective To explore the value of large dose of ambroxol hydrochloride in treating patients with acute exacerbation of chronic obstructive pulmonary disease(AECOPD). Methods Sixty hospitalized patients with moderate-to-severe AECOPD were dived into treatment group and control group at random. The control group was given routine therapy which contained anti-inflammatory,oxygen therapy, antiasthmatic therapy and so on. The treatment group was given ambroxol hydrochloride intravenous drip therapy on basis of the routine therapy. The malonaldehyde(MDA),glutathione reductase(GSH),superoxide dismutase(SOD),FEV1%pre, dyspnea score and so on were measured before and ten days,twenty days after treatment in two groups. The outcomes of two groups were compared. Results In the treatment group,the content of MDA of treatment after treatment ten days and twenty days was lower, the content of GSH and SOD were higher than before treatment;the content of MDA of after treatment twenty days was decreased,the content of GSH and SOD were higher than after treatment ten days, the difference had statistical significance(P<0.05). In the treatment group, the FEV1 % pre of after treatment ten days and twenty days were higher than before treatment,the FEV1 % pre of after treatment twenty days were higher than after treatment ten days, the difference had statistical significance(P<0.05). In the treatment group,the dyspnea score of after treatment ten days and twenty days was decreased than before treatment,the dyspnea score of after treatment twenty days was decreased than after treatment ten days,the difference had statistical significance(P<0.05).The difference of MDA,GSH,SOD,FEV1%pre between after treatment ten days and before treatment, between after treatment twenty days and before treatment, between after treatment ten days and twenty days, and the difference of dyspnea score between after treatment ten days and twenty days in the treatment group and control group all had statistical significance(P<0.05) .Hospitalized days of the treatment group was(11.13±1.94 )days,that of the control group was(13.50± 2.06)days, the average hospitalized days of the treatment group was shorter than the control group,the difference was statistically significance(P<0.05). In treatment group,only two patients had mild gastrointestinal reaction which was relieved after treatment. Conclusion Large dose of ambroxol hydrochloride can increase antioxidative ability, reduce oxidative stress degree of patients with AECOPD, meanwhile can improve patients′ pulmonary function and shorten hospitalized days.
  • loading
  • Relative Articles

    [1] Yichao JIN, Xiaochuan WANG, Chunping AO, Liangheng XU. Pruritus in Keloid:Pathogenesis and Treatments. Journal of Kunming Medical University, 2025, 46(5): 1-5.
    [2] Jing JIANG, Meihua LI, Lifen YANG, Chaofeng REN, Yalin ZHAO, Xingxu LIU, Dongyu ZHOU, Zhangmin ZHENG. Application Value of HBP and PLR in AECOPD. Journal of Kunming Medical University, 2024, 45(10): 116-121.  doi: 10.12259/j.issn.2095-610X.S20241018
    [3] Wei MA, Meihua LI, Jing JIANG, Xingxu LIU, Lifen YANG, Li LI. Advances in the study of heparin-binding protein and serum amyloid A in AECOPD co-infection of the lung. Journal of Kunming Medical University, 2023, 44(2): 172-176.  doi: 10.12259/j.issn.2095-610X.S20230228
    [4] Yang Chao , Du Jun Yi , Pu Dan , Xu Xiao Liang , Chen Min , Liu Ao . . Journal of Kunming Medical University, 2020, 41(09): 120-124.
    [5] Li Rui Jie . Risk-Treatment Paradox in Acute Coronary Syndrome. Journal of Kunming Medical University,
    [6] Cheng Bo . . Journal of Kunming Medical University,
    [7] Yuan Hua Yuan . . Journal of Kunming Medical University,
    [8] Shu Jing Kui . . Journal of Kunming Medical University,
    [9] Liu Ling . . Journal of Kunming Medical University,
    [10] Lin Shao Fang . . Journal of Kunming Medical University,
    [11] Dai Dong Mei . . Journal of Kunming Medical University,
    [12] Zhang Lei . . Journal of Kunming Medical University,
    [13] Yan Bing . . Journal of Kunming Medical University,
    [14] Fang Ke Wei . . Journal of Kunming Medical University,
    [15] Lu Ping . . Journal of Kunming Medical University,
    [16] Huang Ning Yu . . Journal of Kunming Medical University,
    [17] Zhan Hui . Treating Complex Upper Urinary Calculi With Different Type of Channel of Percutaneous Renal Fistula. Journal of Kunming Medical University,
    [18] Tang Ji Hong . Clinical Evaluation on the Treatment of Early Diabetic Nephropathy by Valsartan Combined with Kallidinogenase. Journal of Kunming Medical University,
    [19] . . Journal of Kunming Medical University,
    [20] Chen Zu Cong . . Journal of Kunming Medical University,
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (3117) PDF downloads(136) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return